Unité mixte de recherche sur les processus infectieux en milieu insulaire tropical, INSERM U1187, CNRS 9192, IRD 249, Université de La Réunion-Plateforme Technologique CYROI Sainte-Clotilde, Île de La Réunion, France.
Laboratoire d'immunologie clinique et expérimentale de la zone de l'océan indien CHU La Réunion site Félix Guyon, Allée des Topazes, Saint Denis de La Réunion, France.
PLoS Negl Trop Dis. 2021 Feb 17;15(2):e0009115. doi: 10.1371/journal.pntd.0009115. eCollection 2021 Feb.
Patients following infection by chikungunya virus (CHIKV) can suffer for months to years from arthralgia and arthritis. Interestingly, methotrexate (MTX) a major immune-regulatory drug has proved to be of clinical benefit. We have previously shown that CHIKV can persist in the joint of one patient 18 months post-infection and plausibly driving chronic joint inflammation but through ill-characterized mechanisms. We have pursued our investigations and report novel histological and in vitro data arguing for a plausible role of a COX-2-mediated inflammatory response post-CHIKV. In the joint, we found a robust COX-2 staining on endothelial cells, synovial fibroblasts and more prominently on multinucleated giant cells identified as CD11c+ osteoclasts known to be involved in bone destruction. The joint tissue was also strongly stained for CD3, CD8, CD45, CD14, CD68, CD31, CD34, MMP2, and VEGF (but not for NO synthase and two B cell markers). Dendritic cells were rarely detected. Primary human synovial fibroblasts were infected with CHIKV or stimulated either by the synthetic molecule polyriboinosinic:polyribocytidylic acid (PIC) to mimic chronic viral infection or cytokines. First, we found that PIC and CHIKV enhanced mRNA expression of COX-2. We further found that PIC but not CHIKV increased the mRNA levels of cPLA2α and of mPGES-1, two other central enzymes in PGE2 production. IFNβ upregulated cPLA2α and COX-2 transcription levels but failed to modulated mPGES-1 mRNA expression. Moreover, PIC, CHIKV and IFNβ decreased mRNA expression of the PGE2 degrading enzyme 15-PGDH. Interestingly, MTX failed to control the expression of all these enzymes. In sharp contrast, dexamethasone was able to control the capacity of pro-inflammatory cytokines, IL-1β as well as TNFα, to stimulate mRNA levels of cPLA2α, COX-2 and mPGES-1. These original data argue for a concerted action of CHIKV (including viral RNA) and cytokines plausibly released from recruited leukocytes to drive a major COX-2-mediated PGE2 proinflammatory responses to induce viral arthritis.
感染基孔肯雅病毒(CHIKV)的患者可能会在数月至数年内遭受关节痛和关节炎的折磨。有趣的是,甲氨蝶呤(MTX)作为一种主要的免疫调节药物,已被证明具有临床益处。我们之前曾表明,18 个月后,CHIKV 仍能在一名患者的关节中持续存在,并可能通过尚未明确的机制驱动慢性关节炎症。我们继续进行了研究,并报告了新的组织学和体外数据,这些数据表明 COX-2 介导的炎症反应可能在 CHIKV 后发挥作用。在关节中,我们发现内皮细胞、滑膜成纤维细胞和多核巨细胞(被认为参与骨破坏的 CD11c+破骨细胞)上有强烈的 COX-2 染色。关节组织也强烈染色 CD3、CD8、CD45、CD14、CD68、CD31、CD34、MMP2 和 VEGF(但不染色一氧化氮合酶和两种 B 细胞标志物)。树突状细胞很少被检测到。原代人滑膜成纤维细胞被 CHIKV 感染,或被合成分子聚肌苷酸:聚胞苷酸(PIC)刺激,以模拟慢性病毒感染或细胞因子。首先,我们发现 PIC 和 CHIKV 增强了 COX-2 的 mRNA 表达。我们进一步发现,PIC 但不是 CHIKV 增加了 PGE2 产生的两个关键酶 cPLA2α 和 mPGES-1 的 mRNA 水平。IFNβ 上调了 cPLA2α 和 COX-2 的转录水平,但未能调节 mPGES-1 的 mRNA 表达。此外,PIC、CHIKV 和 IFNβ 降低了 PGE2 降解酶 15-PGDH 的 mRNA 表达。有趣的是,MTX 未能控制所有这些酶的表达。相比之下,地塞米松能够控制促炎细胞因子 IL-1β 和 TNFα 刺激 cPLA2α、COX-2 和 mPGES-1 mRNA 水平的能力。这些原始数据表明,CHIKV(包括病毒 RNA)和细胞因子可能从募集的白细胞中释放出来,共同作用驱动 COX-2 介导的 PGE2 促炎反应,从而引发病毒性关节炎。